What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Leukemia
His primary areas of study are Pathology, Immunology, Bone marrow, Leukemia and Myeloid.
His Pathology study typically links adjacent topics like Monoclonal antibody.
His Immunology research integrates issues from Andrology, Retinoic acid and Family medicine.
His Bone marrow research is classified as research in Internal medicine.
Richard D. Brunning does research in Leukemia, focusing on Acute leukemia specifically.
Richard D. Brunning has researched Myeloid in several fields, including In vivo, Cytochemistry and Basophilic.
His most cited work include:
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
- The World Health Organization (WHO) classification of the myeloid neoplasms. (1819 citations)
- Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. (912 citations)
What are the main themes of his work throughout his whole career to date?
Richard D. Brunning mostly deals with Pathology, Bone marrow, Leukemia, Immunology and Internal medicine.
His research is interdisciplinary, bridging the disciplines of Lymphocyte and Pathology.
The various areas that he examines in his Bone marrow study include Chemotherapy, Trephine, Molecular biology, Biopsy and Cytology.
The Leukemia study combines topics in areas such as Myeloid and Myeloid leukemia.
While working in this field, Richard D. Brunning studies both Immunology and Cytogenetics.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology, Surgery and Oncology.
He most often published in these fields:
- Pathology (55.26%)
- Bone marrow (37.50%)
- Leukemia (37.50%)
What were the highlights of his more recent work (between 1998-2020)?
- Pathology (55.26%)
- Leukemia (37.50%)
- Myelodysplastic syndromes (5.26%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pathology, Leukemia, Myelodysplastic syndromes, Myeloid and Internal medicine.
His Pathology study incorporates themes from Phagocytosis and Peripheral blood.
His studies deal with areas such as Myeloid leukemia and Lymphoma as well as Leukemia.
His Myeloid study improves the overall literature in Immunology.
His Internal medicine research incorporates themes from Gastroenterology, Hypogammaglobulinemia, Oncology and LIGHT CHAIN DISEASE.
His Acute leukemia research is multidisciplinary, incorporating perspectives in Myeloproliferative neoplasm, Preleukemia, Acute erythroid leukemia and Intensive care medicine.
Between 1998 and 2020, his most popular works were:
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
- The World Health Organization (WHO) classification of the myeloid neoplasms. (1819 citations)
- Diagnostic criteria and classification of mastocytosis: a consensus proposal (853 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Leukemia
Richard D. Brunning spends much of his time researching Pathology, Immunology, Bone marrow, Myelodysplastic syndromes and Internal medicine.
His research on Pathology often connects related areas such as Anticorps monoclonal.
His Acute erythroid leukemia, Preleukemia and Myelodysplastic–myeloproliferative diseases study in the realm of Immunology interacts with subjects such as De novo Myelodysplastic Syndrome.
His Bone marrow research is multidisciplinary, relying on both Follicular phase, Hair follicle, Biopsy and Follicular lymphoma, Lymphoma.
His work deals with themes such as Myeloblast and Granulocyte Precursor Cells, which intersect with Myelodysplastic syndromes.
His work in the fields of Internal medicine, such as Hematology, Monoblast and Chronic myelomonocytic leukemia, overlaps with other areas such as Context and Promonocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
